SLC11A1 and metabolic dysfunction-associated steatotic liver disease: In summary, this study identifies ERN1 and SLC11A1 as characteristic IM-FT-related biomarkers, which are significantly differentially expressed in NAFLD and exhibit strong diagnostic performance.